2015 News Releases

Keyword Search
2015 | 2014 | 2013 | 2012 | 2011
06/10/15The Results Are In: S+ by ResMed Users See Improvement in The Amount and Quality of Their Sleep
Data Shows That Among Poor Sleepers, Improved Sleep Knowledge Leads to Improved Sleep SAN DIEGO, June 10, 2015 /PRNewswire/ -- New results from S+ by ResMed, the world's first non-contact sleep system, show that after only one week of use, more than two-thirds of users with below-average sleep scores saw significant improvement. ResMed (NYSE: RMD), the global leader in the treatment of sleep-disordered breathing and other respiratory conditions, announced that 67% of such S+ users saw impro... 
Printer Friendly Version
05/13/15ResMed Provides Update on Phase III SERVE-HF Study of Adaptive Servo-Ventilation (ASV) Therapy In Central Sleep Apnea and Chronic Heart Failure
Study Did Not Meet Primary Endpoint Safety Signal of Increased Cardiovascular Mortality Found For ASV Therapy In People With Predominant Central Sleep Apnea and Symptomatic Chronic Heart Failure Results and Safety Signal Observed Only In This Specific Study Population SAN DIEGO, May 13, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) today announced that SERVE-HF, a multinational, multicenter, randomized controlled Phase III trial did not meet its primary endpoint.  SERVE-HF was designed to a... 
Printer Friendly Version
04/30/15ResMed Introduces Lumis Series of Noninvasive Ventilators for Personalized, Simplified and Connected Care
- IntelligentAir technology, a ResMed first, tailors therapy to individual breathing needs - Built-in wireless connectivity makes for easy patient monitoring and management SAN DIEGO, April 30, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) today announced its Lumis™ series of noninvasive ventilation devices that combine personalized, simplified therapy with powerful wireless connected care capabilities. The Lumis series builds upon ResMed's legacy of innovation as a new option for patients wit... 
Printer Friendly Version
04/23/15ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2015
Revenue increased 6% to $422 million; up 13% on a constant currency basis GAAP diluted earnings per share of $0.64, or non-GAAP earnings per share of $0.65 Operating cash flow of $90.9 million Company repurchased 300,000 shares in the third quarter SAN DIEGO, April 23, 2015 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended March 31, 2015.  Revenue for the quarter was $422.5 million, a 6 percent increase compared to the quarter ended March 31, 201... 
Printer Friendly Version
04/02/15ResMed To Announce Third Quarter 2015 Results
SAN DIEGO, April 2, 2015 /PRNewswire/ -- RESMED INC. (NYSE: RMD) today announced that it will report its third quarter of fiscal year 2015 results on Thursday, April 23, 2015, after the New York Stock Exchange market close. A press release with ResMed's results will be issued after 1:00 p.m. US Pacific Time and the company will host a webcast to discuss operating results and future outlook. The earnings call is scheduled to begin at 1:30 p.m. US Pacific Time and the live webcast of the call c... 
Printer Friendly Version
03/12/15ResMed to Present New Data on Sleep-Disordered Breathing in Patients with Chronic Heart Failure at the American College of Cardiology 64th Annual Meeting
SAN DIEGO, March 12, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) today announced data from two studies about sleep-disordered breathing (SDB) in chronic heart failure will be presented at the 64th Annual Scientific Sessions of the American College of Cardiology, from March 14th through 16th. "The data we are presenting are important because they point toward a connection between breathing disorders in sleep, like sleep apnea, and chronic heart failure," said ResMed Chief Medical Officer, Glenn R... 
Printer Friendly Version
02/12/15ResMed Wins Continued Injunction Against BMC in German Patent Infringement Action
Ruling Prevents Sale of Infringing BMC Masks in Germany MUNICH, Germany and SAN DIEGO, Calif., Feb. 12, 2015 /PRNewswire/ -- ResMed (NYSE:RMD) today announced that the Munich District Court upheld its injunction against Chinese medical device manufacturer BMC Medical Co., Ltd. (BMC). The injunction prohibits BMC from offering, selling or distributing infringing mask products in Germany. The Munich Court's preliminary injunction decision, first rendered in November 2013, and continued in... 
Printer Friendly Version
02/10/15ResMed Acquires Jaysec, a Leader in Internet-Based Software Solutions for Home Medical Equipment Providers
SAN DIEGO, Feb. 10, 2015 /PRNewswire/ -- ResMed (NYSE:RMD) today announced it has acquired Jaysec, a provider of Internet-based software solutions for the home medical equipment (HME) industry. Headquartered in Knoxville, Tenn., Jaysec's products help HME providers resupply their patients and communicate with referring medical providers. "Jaysec's products streamline key HME business practices such as resupply, allowing home medical equipment providers to focus on delivering quality care for ... 
Printer Friendly Version
02/02/15Easy-to-Use AirView™ Patient Management System by ResMed Now Integrates Directly with Brightree
HMEs Benefit From Powerful new Capabilities for Faster Patient On-Boarding and On-Demand Compliance Data - all in one Software Environment SAN DIEGO and ATLANTA, Feb. 2, 2015 /PRNewswire/ -- ResMed (NYSE: RMD) and Brightree today announced ResMed's AirView patient management system will directly integrate with Brightree's leading home medical equipment (HME) billing and business management software solution. "Since 2013, Brightree and ResMed have partnered to bring greater workflow effi... 
Printer Friendly Version
01/22/15ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015
Second quarter revenue increased 10% to $423 million; up 14% on a constant currency basis Second quarter GAAP diluted earnings per share of $0.64 Second quarter operating cash flow of $106.0 million Company repurchased 667,000 shares in the second quarter SAN DIEGO, Jan. 22, 2015 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced results for its quarter ended December 31, 2014. Revenue for the quarter was $423.0 million, a 10 percent increase compared to the quarter ended Dece... 
Printer Friendly Version